Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes - PubMed (original) (raw)
Multicenter Study
. 2008 Jul;31(7):1389-91.
doi: 10.2337/dc08-0194. Epub 2008 Mar 28.
Affiliations
- PMID: 18375411
- PMCID: PMC2453666
- DOI: 10.2337/dc08-0194
Multicenter Study
Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes
Ioanna Gouni-Berthold et al. Diabetes Care. 2008 Jul.
Abstract
Objective: To assess whether sex differences exist in the effective control and medication treatment intensity of cardiovascular disease (CVD) risk factors.
Research design and methods: We performed a cross-sectional analysis including 44,893 patients with type 2 diabetes (51% women). End points included uncontrolled CVD risk factors (LDL cholesterol > or =130 mg/dl, systolic blood pressure [SBP] > or =140 mmHg, and A1C > or =8%) and the intensity of medical management in patients with uncontrolled CVD risk factors. Multiple-adjusted odds ratios were calculated after stratification for the presence of CVD (present in 39% of the patients).
Results: Women with CVD were less likely to have SBP, LDL cholesterol, and A1C controlled and less likely to receive intensive lipid-lowering treatment. Women without CVD were less likely than men to have LDL cholesterol controlled with no differences in SBP or A1C control.
Conclusions: Women with diabetes and CVD have poorer control of important modifiable risk factors than men and receive less intensified lipid-lowering treatment.
Similar articles
- Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Stevens M, Selby JV; Translating Research Into Action for Diabetes Study Group. Ferrara A, et al. Diabetes Care. 2008 Jan;31(1):69-74. doi: 10.2337/dc07-1244. Epub 2007 Oct 12. Diabetes Care. 2008. PMID: 17934157 - Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
Strom Williams JL, Lynch CP, Winchester R, Thomas L, Keith B, Egede LE. Strom Williams JL, et al. Diabetes Technol Ther. 2014 Jul;16(7):421-7. doi: 10.1089/dia.2013.0329. Epub 2014 Apr 15. Diabetes Technol Ther. 2014. PMID: 24735058 Free PMC article. - Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
Nichols GA, Joshua-Gotlib S, Parasuraman S. Nichols GA, et al. J Gen Intern Med. 2013 May;28(5):691-7. doi: 10.1007/s11606-012-2320-1. Epub 2013 Jan 24. J Gen Intern Med. 2013. PMID: 23345072 Free PMC article. - Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?
Reddy SV, Bhatia E. Reddy SV, et al. Natl Med J India. 2011 Jan-Feb;24(1):21-7. Natl Med J India. 2011. PMID: 21608354 Review. - Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
Camara S, Bouenizabila E, Hermans MP, Ahn SA, Rousseau MF. Camara S, et al. Diabetes Metab Syndr. 2014 Jul-Sep;8(3):145-51. doi: 10.1016/j.dsx.2014.04.037. Epub 2014 Jun 16. Diabetes Metab Syndr. 2014. PMID: 25220917 Review.
Cited by
- Associations between sex and incident chronic kidney disease in a prospective diabetic cohort.
Yu MK, Katon W, Young BA. Yu MK, et al. Nephrology (Carlton). 2015 Jul;20(7):451-8. doi: 10.1111/nep.12468. Nephrology (Carlton). 2015. PMID: 25807970 Free PMC article. - Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study.
Fujita Y, Morimoto T, Tokushige A, Ikeda M, Shimabukuro M, Node K, Ueda S. Fujita Y, et al. BMJ Open Diabetes Res Care. 2022 Apr;10(2):e002707. doi: 10.1136/bmjdrc-2021-002707. BMJ Open Diabetes Res Care. 2022. PMID: 35473826 Free PMC article. - Sex differences in the risk of vascular disease associated with diabetes.
de Ritter R, de Jong M, Vos RC, van der Kallen CJH, Sep SJS, Woodward M, Stehouwer CDA, Bots ML, Peters SAE. de Ritter R, et al. Biol Sex Differ. 2020 Jan 3;11(1):1. doi: 10.1186/s13293-019-0277-z. Biol Sex Differ. 2020. PMID: 31900228 Free PMC article. Review. - Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study.
Yu MK, Lyles CR, Bent-Shaw LA, Young BA; Pathways Authors. Yu MK, et al. Am J Nephrol. 2012;36(3):245-51. doi: 10.1159/000342210. Epub 2012 Sep 4. Am J Nephrol. 2012. PMID: 22964976 Free PMC article. - Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men.
Brar V, Gill S, Cardillo C, Tesauro M, Panza JA, Campia U. Brar V, et al. PLoS One. 2015 Mar 25;10(3):e0121810. doi: 10.1371/journal.pone.0121810. eCollection 2015. PLoS One. 2015. PMID: 25807234 Free PMC article.
References
- Hartel U: [Gender issues in the epidemiology of cardiovascular diseases]. Ther Umsch 64:297–304, 2007. [in German] - PubMed
- Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297, 1999 - PubMed
- Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E: Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28:514–520, 2005 - PubMed
- Ferrara A, Williamson DF, Karter AJ, Thompson TJ, Kim C: Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes. Diabetes Care 27:2974–2976, 2004 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical